The 74 rating InvestorsObserver gives to MiMedx Group Inc (MDXG) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 88 percent of stocks in the Biotechnology industry, MDXG’s 74 overall rating means the stock scores better than 74 percent of all stocks.
MDXG has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on MDXG!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With MiMedx Group Inc Stock Today?
MiMedx Group Inc (MDXG) stock is down -0.66% while the S&P 500 has risen 0.39% as of 2:43 PM on Wednesday, Mar 27. MDXG is lower by -$0.05 from the previous closing price of $7.62 on volume of 1,328,973 shares. Over the past year the S&P 500 has risen 31.54% while MDXG has risen 127.33%. MDXG earned $0.49 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 15.46.
Click Here to get the full Stock Report for MiMedx Group Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
